PHARMACY

Teva intros generic Diclegis

BY Sandra Levy

Teva is introducing doxylamine succinate and pyridoxine hydrochloride delayed-release tablets in a dosage strength of 10/mg/10 mg.

The product is the generic of Duchesnay’s Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets 10 mg/10 mg, and used to treat nausea and vomiting of pregnancy in women who have not improved with change in diet or other non-medicine treatments.

Teva’s product is available in bottles of 100.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer